SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (164)7/14/1999 11:14:00 PM
From: Impristine-2  Respond to of 2557
 
So David,
Are you saying the molecule
is odoriferous,
and if i smell it,
the truth will set me free...
Something does smell Bad...

God Bless America!



To: LLCF who wrote (164)7/15/1999 10:00:00 AM
From: CoffeePot  Respond to of 2557
 
Yesterdays news was IMO a non-event,, Pleconaril's intended value is in completely inhibiting viral infection thus preventing a cold....which has and was not clinically proven in phase II trials.....reducing the length of the common cold from 14 to 11 days is not a medical breakthough as there are many products already on the market that have performed much better than this Message 10511341
without CNBC Viropharma would still be @ $10-12 where it belongs. IMO